CCL1 and metabolic dysfunction-associated steatotic liver disease: In the study of NAFLD, researchers designed two different fluorescein substrates (FFA-luc and CCL-1) to meet the needs of the research purpose (Henkin et al., 2012; Heffern et al., 2016).